Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Multicenter, Open-Label, Interventional Study Comparing Survival in Subjects Receiving Peritoneal Dialysis vs Hemodialysis in China

NCT01413074 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT01413074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01413074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Multicenter, Open-Label, Interventional Study Comparing Survival in Subjects Receiving Peritoneal Dialysis vs Hemodialysis in China
Lead sponsor
Vantive Health LLC
Phase
Not applicable
Overall status
Terminated
Start date
June 30, 2011
Completion date
December 31, 2013
Enrollment
416 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease